| Literature DB >> 14565243 |
Gabriele Dorn1, Jonathan Hall, Dieter Hüsken, Jörg Lange, Pierre Martin, Francois Natt, William L Wishart, Jan Weiler.
Abstract
Functional genomics is inundating the pharmaceutical industry with large numbers of potential gene targets from several sources such as gene expression profiling experiments (DNA microchips, proteomics) or database mining. Oligonucleotide-based RNA-knock down technologies such as antisense or RNA interference can aid in the filtering and prioritization of target candidates in the drug discovery process.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14565243 DOI： 10.1081/NCN-120021970
Source DB: PubMed Journal: Nucleosides Nucleotides Nucleic Acids ISSN： 1525-7770 Impact factor: 1.381